<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC7235062</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC7235062.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">7235062</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">7235062</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">31705427</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1007/s12975-019-00741-8</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">741</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Baseline clinical and MRI characteristics of the total cohort and comparison of subgroups according to the median split of the cavitation index</table-caption><table-wrap-foot>*Sum of periventricular (0–3) and deep (0–3) WMH scores#Available in 42 patients (n = 22 with cavitation index ≤ 7%; n = 20 with cavitation index &gt; 7%)SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; FU, follow-up; RSSI, recent small subcortical infarct; PVS, perivascular spaces; IQR, interquartile range; ACE-R, Addenbrooke’s Cognitive Examination Revised</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline clinical and MRI characteristics of the total cohort and comparison of subgroups according to the median split of the <italic toggle="yes">cavitation index</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Variables</th><th rowspan="2" colspan="1">Total cohort, <italic toggle="yes">n</italic> = 60</th><th colspan="1" rowspan="1">Cavitation index ≤ 7%</th><th colspan="1" rowspan="1">Cavitation index &gt; 7%</th><th rowspan="2" colspan="1"><italic toggle="yes">p</italic> value</th></tr><tr><th colspan="1" rowspan="1"><italic toggle="yes">N</italic> = 29</th><th colspan="1" rowspan="1"><italic toggle="yes">N</italic> = 31</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age in years, mean (± SD)</td><td colspan="1" rowspan="1">65.1 (10.6)</td><td colspan="1" rowspan="1">66.1 (9.8)</td><td colspan="1" rowspan="1">64.1 (11.4)</td><td colspan="1" rowspan="1">0.47</td></tr><tr><td colspan="1" rowspan="1">Male sex, <italic toggle="yes">n</italic> (%)</td><td colspan="1" rowspan="1">39 (65)</td><td colspan="1" rowspan="1">21 (72)</td><td colspan="1" rowspan="1">18 (58)</td><td colspan="1" rowspan="1">0.65</td></tr><tr><td colspan="1" rowspan="1">NIHSS, median (range)</td><td colspan="1" rowspan="1">1 (0–7)</td><td colspan="1" rowspan="1">1 (0–5)</td><td colspan="1" rowspan="1">1 (0–7)</td><td colspan="1" rowspan="1">0.20</td></tr><tr><td colspan="1" rowspan="1">Modified Rankin Scale, median (IQR)</td><td colspan="1" rowspan="1">1 (2)</td><td colspan="1" rowspan="1">1 (1)</td><td colspan="1" rowspan="1">2 (2)</td><td colspan="1" rowspan="1">0.170</td></tr><tr><td colspan="5" rowspan="1">Vascular risk factors, <italic toggle="yes">n</italic> (%)</td></tr><tr><td colspan="1" rowspan="1">  Hypertension</td><td colspan="1" rowspan="1">46 (77)</td><td colspan="1" rowspan="1">26 (84)</td><td colspan="1" rowspan="1">20 (69)</td><td colspan="1" rowspan="1">0.17</td></tr><tr><td colspan="1" rowspan="1">  Diabetes</td><td colspan="1" rowspan="1">6 (10)</td><td colspan="1" rowspan="1">4 (13)</td><td colspan="1" rowspan="1">2 (7)</td><td colspan="1" rowspan="1">0.44</td></tr><tr><td colspan="1" rowspan="1">  Hyperlipidemia</td><td colspan="1" rowspan="1">39 (65)</td><td colspan="1" rowspan="1">20 (65)</td><td colspan="1" rowspan="1">19 (66)</td><td colspan="1" rowspan="1">0.94</td></tr><tr><td colspan="1" rowspan="1">  Smoking</td><td colspan="1" rowspan="1">24 (40)</td><td colspan="1" rowspan="1">12 (39)</td><td colspan="1" rowspan="1">12 (41)</td><td colspan="1" rowspan="1">0.83</td></tr><tr><td colspan="5" rowspan="1">Baseline MRI characteristics</td></tr><tr><td colspan="1" rowspan="1">  Symptom onset to baseline MRI in days, median (IQR)</td><td colspan="1" rowspan="1">4 (4)</td><td colspan="1" rowspan="1">4 (5)</td><td colspan="1" rowspan="1">4 (3.5)</td><td colspan="1" rowspan="1">0.79</td></tr><tr><td colspan="1" rowspan="1">  Symptom onset to FU 1 MRI in days, median (IQR)</td><td colspan="1" rowspan="1">45 (29)</td><td colspan="1" rowspan="1">47.5 (28.25)</td><td colspan="1" rowspan="1">41 (31)</td><td colspan="1" rowspan="1">0.33</td></tr><tr><td colspan="1" rowspan="1">  Symptom onset to FU 2 MRI in days, median (IQR)</td><td colspan="1" rowspan="1">386 (53)</td><td colspan="1" rowspan="1">392 (65.25)</td><td colspan="1" rowspan="1">384 (49)</td><td colspan="1" rowspan="1">0.41</td></tr><tr><td colspan="1" rowspan="1">  Maximal axial RSSI diameter in mm, median (IQR)</td><td colspan="1" rowspan="1">12 (7)</td><td colspan="1" rowspan="1">12 (6)</td><td colspan="1" rowspan="1">10.5 (7.6)</td><td colspan="1" rowspan="1">0.29</td></tr><tr><td colspan="1" rowspan="1">  RSSI location, <italic toggle="yes">n</italic> (%)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0.42</td></tr><tr><td colspan="1" rowspan="1">    Basal ganglia/internal capsule</td><td colspan="1" rowspan="1">15 (25)</td><td colspan="1" rowspan="1">7 (23)</td><td colspan="1" rowspan="1">8 (28)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">    Centrum semiovale</td><td colspan="1" rowspan="1">25 (42)</td><td colspan="1" rowspan="1">15 (48)</td><td colspan="1" rowspan="1">10 (35)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">    Thalamus</td><td colspan="1" rowspan="1">14 (23)</td><td colspan="1" rowspan="1">5 (16)</td><td colspan="1" rowspan="1">9 (31)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">    Brainstem</td><td colspan="1" rowspan="1">6 (10)</td><td colspan="1" rowspan="1">4 (13)</td><td colspan="1" rowspan="1">2 (7)</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">  Fazekas WMH sum score* (0–6), median (IQR)</td><td colspan="1" rowspan="1">3 (3)</td><td colspan="1" rowspan="1">3.5 (1–6)</td><td colspan="1" rowspan="1">3 (2–6)</td><td colspan="1" rowspan="1">0.16</td></tr><tr><td colspan="1" rowspan="1">  Lacunar infarcts ≥ 1, <italic toggle="yes">n</italic> (%)</td><td colspan="1" rowspan="1">30 (50)</td><td colspan="1" rowspan="1">16 (52)</td><td colspan="1" rowspan="1">14 (48)</td><td colspan="1" rowspan="1">0.8</td></tr><tr><td colspan="1" rowspan="1">  Microbleeds ≥ 1, <italic toggle="yes">n</italic> (%)</td><td colspan="1" rowspan="1">17 (28)</td><td colspan="1" rowspan="1">12 (40)</td><td colspan="1" rowspan="1">5 (17)</td><td colspan="1" rowspan="1">0.054</td></tr><tr><td colspan="1" rowspan="1">  PVS in basal ganglia (0–4), median (IQR)</td><td colspan="1" rowspan="1">2 (2)</td><td colspan="1" rowspan="1">2 (1–4)</td><td colspan="1" rowspan="1">2 (1–4)</td><td colspan="1" rowspan="1">0.97</td></tr><tr><td colspan="1" rowspan="1">  PVS in centrum semiovale (0–4), median (IQR)</td><td colspan="1" rowspan="1">2 (2)</td><td colspan="1" rowspan="1">2 (0–4)</td><td colspan="1" rowspan="1">2 (1–4)</td><td colspan="1" rowspan="1">0.73</td></tr><tr><td colspan="1" rowspan="1">  Deep atrophy score (0–3), median (IQR)</td><td colspan="1" rowspan="1">1 (1)</td><td colspan="1" rowspan="1">1 (0–3)</td><td colspan="1" rowspan="1">1 (0–3)</td><td colspan="1" rowspan="1">0.047</td></tr><tr><td colspan="1" rowspan="1">  Superficial atrophy score (0–3), median (IQR)</td><td colspan="1" rowspan="1">1 (1)</td><td colspan="1" rowspan="1">1 (0–3)</td><td colspan="1" rowspan="1">1 (0–2)</td><td colspan="1" rowspan="1">0.56</td></tr><tr><td colspan="1" rowspan="1">Cavitation index at 1 year, median (range)</td><td colspan="1" rowspan="1">0.071 (0.01–0.36)</td><td colspan="1" rowspan="1">0.045 (0.01–0.07)</td><td colspan="1" rowspan="1">0.116 (0.08–0.36)</td><td colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td colspan="1" rowspan="1">Modified Rankin Scale at 1 year, median (IQR)</td><td colspan="1" rowspan="1">1 (1)</td><td colspan="1" rowspan="1">1 (2)</td><td colspan="1" rowspan="1">1 (1)</td><td colspan="1" rowspan="1">0.476</td></tr><tr><td colspan="1" rowspan="1">ACE-R [<xref ref-type="bibr" rid="CR37">37</xref>] at 1 year, median (IQR)#</td><td colspan="1" rowspan="1">90 (13)</td><td colspan="1" rowspan="1">91.5 (12)</td><td colspan="1" rowspan="1">88.5 (15)</td><td colspan="1" rowspan="1">0.52</td></tr></tbody></table><table-wrap-foot><p>*Sum of periventricular (0–3) and deep (0–3) WMH scores</p><p>#Available in 42 patients (<italic toggle="yes">n</italic> = 22 with cavitation index ≤ 7%; <italic toggle="yes">n</italic> = 20 with cavitation index &gt; 7%)</p><p><italic toggle="yes">SD</italic>, standard deviation; <italic toggle="yes">NIHSS</italic>, National Institutes of Health Stroke Scale; <italic toggle="yes">FU</italic>, follow-up; <italic toggle="yes">RSSI</italic>, recent small subcortical infarct; <italic toggle="yes">PVS</italic>, perivascular spaces; <italic toggle="yes">IQR</italic>, interquartile range; <italic toggle="yes">ACE-R</italic>, Addenbrooke’s Cognitive Examination Revised</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline clinical and MRI characteristics of the total cohort and comparison of subgroups according to the median split of the cavitation index</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Variables</th><th rowspan="2">Total cohort, n = 60</th><th>Cavitation index ≤ 7%</th><th>Cavitation index &gt; 7%</th><th rowspan="2">p value</th></tr><tr><th>N = 29</th><th>N = 31</th></tr></thead><tbody><tr><td>Age in years, mean (± SD)</td><td>65.1 (10.6)</td><td>66.1 (9.8)</td><td>64.1 (11.4)</td><td>0.47</td></tr><tr><td>Male sex, n (%)</td><td>39 (65)</td><td>21 (72)</td><td>18 (58)</td><td>0.65</td></tr><tr><td>NIHSS, median (range)</td><td>1 (0–7)</td><td>1 (0–5)</td><td>1 (0–7)</td><td>0.20</td></tr><tr><td>Modified Rankin Scale, median (IQR)</td><td>1 (2)</td><td>1 (1)</td><td>2 (2)</td><td>0.170</td></tr><tr><td colspan="5">Vascular risk factors, n (%)</td></tr><tr><td>  Hypertension</td><td>46 (77)</td><td>26 (84)</td><td>20 (69)</td><td>0.17</td></tr><tr><td>  Diabetes</td><td>6 (10)</td><td>4 (13)</td><td>2 (7)</td><td>0.44</td></tr><tr><td>  Hyperlipidemia</td><td>39 (65)</td><td>20 (65)</td><td>19 (66)</td><td>0.94</td></tr><tr><td>  Smoking</td><td>24 (40)</td><td>12 (39)</td><td>12 (41)</td><td>0.83</td></tr><tr><td colspan="5">Baseline MRI characteristics</td></tr><tr><td>  Symptom onset to baseline MRI in days, median (IQR)</td><td>4 (4)</td><td>4 (5)</td><td>4 (3.5)</td><td>0.79</td></tr><tr><td>  Symptom onset to FU 1 MRI in days, median (IQR)</td><td>45 (29)</td><td>47.5 (28.25)</td><td>41 (31)</td><td>0.33</td></tr><tr><td>  Symptom onset to FU 2 MRI in days, median (IQR)</td><td>386 (53)</td><td>392 (65.25)</td><td>384 (49)</td><td>0.41</td></tr><tr><td>  Maximal axial RSSI diameter in mm, median (IQR)</td><td>12 (7)</td><td>12 (6)</td><td>10.5 (7.6)</td><td>0.29</td></tr><tr><td>  RSSI location, n (%)</td><td/><td/><td/><td>0.42</td></tr><tr><td>    Basal ganglia/internal capsule</td><td>15 (25)</td><td>7 (23)</td><td>8 (28)</td><td/></tr><tr><td>    Centrum semiovale</td><td>25 (42)</td><td>15 (48)</td><td>10 (35)</td><td/></tr><tr><td>    Thalamus</td><td>14 (23)</td><td>5 (16)</td><td>9 (31)</td><td/></tr><tr><td>    Brainstem</td><td>6 (10)</td><td>4 (13)</td><td>2 (7)</td><td/></tr><tr><td>  Fazekas WMH sum score* (0–6), median (IQR)</td><td>3 (3)</td><td>3.5 (1–6)</td><td>3 (2–6)</td><td>0.16</td></tr><tr><td>  Lacunar infarcts ≥ 1, n (%)</td><td>30 (50)</td><td>16 (52)</td><td>14 (48)</td><td>0.8</td></tr><tr><td>  Microbleeds ≥ 1, n (%)</td><td>17 (28)</td><td>12 (40)</td><td>5 (17)</td><td>0.054</td></tr><tr><td>  PVS in basal ganglia (0–4), median (IQR)</td><td>2 (2)</td><td>2 (1–4)</td><td>2 (1–4)</td><td>0.97</td></tr><tr><td>  PVS in centrum semiovale (0–4), median (IQR)</td><td>2 (2)</td><td>2 (0–4)</td><td>2 (1–4)</td><td>0.73</td></tr><tr><td>  Deep atrophy score (0–3), median (IQR)</td><td>1 (1)</td><td>1 (0–3)</td><td>1 (0–3)</td><td>0.047</td></tr><tr><td>  Superficial atrophy score (0–3), median (IQR)</td><td>1 (1)</td><td>1 (0–3)</td><td>1 (0–2)</td><td>0.56</td></tr><tr><td>Cavitation index at 1 year, median (range)</td><td>0.071 (0.01–0.36)</td><td>0.045 (0.01–0.07)</td><td>0.116 (0.08–0.36)</td><td>&lt; 0.001</td></tr><tr><td>Modified Rankin Scale at 1 year, median (IQR)</td><td>1 (1)</td><td>1 (2)</td><td>1 (1)</td><td>0.476</td></tr><tr><td>ACE-R [???] at 1 year, median (IQR)#</td><td>90 (13)</td><td>91.5 (12)</td><td>88.5 (15)</td><td>0.52</td></tr></tbody></table></div>*Sum of periventricular (0–3) and deep (0–3) WMH scores#Available in 42 patients (n = 22 with cavitation index ≤ 7%; n = 20 with cavitation index &gt; 7%)SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; FU, follow-up; RSSI, recent small subcortical infarct; PVS, perivascular spaces; IQR, interquartile range; ACE-R, Addenbrooke’s Cognitive Examination Revised</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Bivariate correlations of clinical and MRI parameters with cavitation index</table-caption><table-wrap-foot>*BBB analyses were available in 59 patients (DCE data not available for 1 patient)# Available in 42 patientsNIHSS, National Institutes of Health Stroke Scale; AUC, area under the curve; RSSI, recent small subcortical infarct; DTI, diffusion tensor imaging; WMH, white matter hyperintensities; MD, mean diffusivity; FA, fractional anisotropy; ACE-R, Addenbrooke’s Cognitive Examination Revised</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Bivariate correlations of clinical and MRI parameters with <italic toggle="yes">cavitation index</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">Spearman correlation coefficient</th><th colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td colspan="3" rowspan="1">Baseline variables</td></tr><tr><td colspan="1" rowspan="1">  Age</td><td colspan="1" rowspan="1">− 0.096</td><td colspan="1" rowspan="1">0.47</td></tr><tr><td colspan="1" rowspan="1">  NIHSS</td><td colspan="1" rowspan="1">0.060</td><td colspan="1" rowspan="1">0.65</td></tr><tr><td colspan="1" rowspan="1">  Time stroke symptom onset to MRI at baseline</td><td colspan="1" rowspan="1">− 0.074</td><td colspan="1" rowspan="1">0.58</td></tr><tr><td colspan="1" rowspan="1">  Time stroke symptom onset to MRI at follow-up 1 (BBB measurements)</td><td colspan="1" rowspan="1">− 0.083</td><td colspan="1" rowspan="1">0.53</td></tr><tr><td colspan="1" rowspan="1">  Time stroke symptom onset to MRI at follow-up 2 (rating of tissue outcome)</td><td colspan="1" rowspan="1">− 0.203</td><td colspan="1" rowspan="1">0.12</td></tr><tr><td colspan="1" rowspan="1">  RSSI maximal diameter</td><td colspan="1" rowspan="1">− 0.142</td><td colspan="1" rowspan="1">0.28</td></tr><tr><td colspan="1" rowspan="1">  RSSI volume</td><td colspan="1" rowspan="1">− 0.140</td><td colspan="1" rowspan="1">0.29</td></tr><tr><td colspan="1" rowspan="1">  WMH periventricular</td><td colspan="1" rowspan="1">− 0.092</td><td colspan="1" rowspan="1">0.49</td></tr><tr><td colspan="1" rowspan="1">  WMH deep</td><td colspan="1" rowspan="1">− 0.178</td><td colspan="1" rowspan="1">0.18</td></tr><tr><td colspan="1" rowspan="1">  WMH sum score</td><td colspan="1" rowspan="1">− 0.137</td><td colspan="1" rowspan="1">0.30</td></tr><tr><td colspan="1" rowspan="1">  Deep atrophy score</td><td colspan="1" rowspan="1">− 0.210</td><td colspan="1" rowspan="1">0.11</td></tr><tr><td colspan="1" rowspan="1">  Superficial atrophy score</td><td colspan="1" rowspan="1">− 0.138</td><td colspan="1" rowspan="1">0.31</td></tr><tr><td colspan="1" rowspan="1">  Number of microbleeds</td><td colspan="1" rowspan="1">− 0.186</td><td colspan="1" rowspan="1">0.16</td></tr><tr><td colspan="1" rowspan="1">  Number of old lacunes</td><td colspan="1" rowspan="1">0.118</td><td colspan="1" rowspan="1">0.37</td></tr><tr><td colspan="3" rowspan="1">DTI parameters at baseline</td></tr><tr><td colspan="1" rowspan="1">  Median FA of normal-appearing white matter</td><td colspan="1" rowspan="1">− 0.001</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">  Median MD of normal-appearing white matter</td><td colspan="1" rowspan="1">0.012</td><td colspan="1" rowspan="1">0.93</td></tr><tr><td colspan="1" rowspan="1">  Median FA of RSSI (corrected for contralateral control region)</td><td colspan="1" rowspan="1">− 0.084</td><td colspan="1" rowspan="1">0.52</td></tr><tr><td colspan="1" rowspan="1">  Median MD of RSSI (corrected for contralateral control region)</td><td colspan="1" rowspan="1"><italic toggle="yes">− 0.371</italic></td><td colspan="1" rowspan="1"><italic toggle="yes">0.004</italic></td></tr><tr><td colspan="3" rowspan="1">BBB measures at 1–3-month post-stroke*</td></tr><tr><td colspan="1" rowspan="1">  Normalized AUC CSF</td><td colspan="1" rowspan="1"><italic toggle="yes">0.347</italic></td><td colspan="1" rowspan="1"><italic toggle="yes">0.007</italic></td></tr><tr><td colspan="1" rowspan="1">  Normalized AUC gray matter</td><td colspan="1" rowspan="1">0.218</td><td colspan="1" rowspan="1">0.10</td></tr><tr><td colspan="1" rowspan="1">  Normalized AUC white matter</td><td colspan="1" rowspan="1">0.080</td><td colspan="1" rowspan="1">0.55</td></tr><tr><td colspan="1" rowspan="1">  Normalized AUC white matter lesions</td><td colspan="1" rowspan="1">0.109</td><td colspan="1" rowspan="1">0.41</td></tr><tr><td colspan="1" rowspan="1">  Normalized AUC RSSI</td><td colspan="1" rowspan="1">− 0.014</td><td colspan="1" rowspan="1">0.92</td></tr><tr><td colspan="3" rowspan="1">Clinical outcome at 1 year</td></tr><tr><td colspan="1" rowspan="1">Modified Rankin scale</td><td colspan="1" rowspan="1">0.149</td><td colspan="1" rowspan="1">0.26</td></tr><tr><td colspan="1" rowspan="1">ACE-R [<xref ref-type="bibr" rid="CR37">37</xref>] #</td><td colspan="1" rowspan="1">− 0.067</td><td colspan="1" rowspan="1">0.67</td></tr></tbody></table><table-wrap-foot><p>*BBB analyses were available in 59 patients (DCE data not available for 1 patient)</p><p># Available in 42 patients</p><p><italic toggle="yes">NIHSS</italic>, National Institutes of Health Stroke Scale; <italic toggle="yes">AUC</italic>, area under the curve; <italic toggle="yes">RSSI</italic>, recent small subcortical infarct; <italic toggle="yes">DTI</italic>, diffusion tensor imaging; <italic toggle="yes">WMH</italic>, white matter hyperintensities; <italic toggle="yes">MD</italic>, mean diffusivity; <italic toggle="yes">FA</italic>, fractional anisotropy; <italic toggle="yes">ACE-R</italic>, Addenbrooke’s Cognitive Examination Revised</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Bivariate correlations of clinical and MRI parameters with cavitation index</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Spearman correlation coefficient</th><th>p value</th></tr></thead><tbody><tr><td colspan="3">Baseline variables</td></tr><tr><td>  Age</td><td>− 0.096</td><td>0.47</td></tr><tr><td>  NIHSS</td><td>0.060</td><td>0.65</td></tr><tr><td>  Time stroke symptom onset to MRI at baseline</td><td>− 0.074</td><td>0.58</td></tr><tr><td>  Time stroke symptom onset to MRI at follow-up 1 (BBB measurements)</td><td>− 0.083</td><td>0.53</td></tr><tr><td>  Time stroke symptom onset to MRI at follow-up 2 (rating of tissue outcome)</td><td>− 0.203</td><td>0.12</td></tr><tr><td>  RSSI maximal diameter</td><td>− 0.142</td><td>0.28</td></tr><tr><td>  RSSI volume</td><td>− 0.140</td><td>0.29</td></tr><tr><td>  WMH periventricular</td><td>− 0.092</td><td>0.49</td></tr><tr><td>  WMH deep</td><td>− 0.178</td><td>0.18</td></tr><tr><td>  WMH sum score</td><td>− 0.137</td><td>0.30</td></tr><tr><td>  Deep atrophy score</td><td>− 0.210</td><td>0.11</td></tr><tr><td>  Superficial atrophy score</td><td>− 0.138</td><td>0.31</td></tr><tr><td>  Number of microbleeds</td><td>− 0.186</td><td>0.16</td></tr><tr><td>  Number of old lacunes</td><td>0.118</td><td>0.37</td></tr><tr><td colspan="3">DTI parameters at baseline</td></tr><tr><td>  Median FA of normal-appearing white matter</td><td>− 0.001</td><td>1</td></tr><tr><td>  Median MD of normal-appearing white matter</td><td>0.012</td><td>0.93</td></tr><tr><td>  Median FA of RSSI (corrected for contralateral control region)</td><td>− 0.084</td><td>0.52</td></tr><tr><td>  Median MD of RSSI (corrected for contralateral control region)</td><td>− 0.371</td><td>0.004</td></tr><tr><td colspan="3">BBB measures at 1–3-month post-stroke*</td></tr><tr><td>  Normalized AUC CSF</td><td>0.347</td><td>0.007</td></tr><tr><td>  Normalized AUC gray matter</td><td>0.218</td><td>0.10</td></tr><tr><td>  Normalized AUC white matter</td><td>0.080</td><td>0.55</td></tr><tr><td>  Normalized AUC white matter lesions</td><td>0.109</td><td>0.41</td></tr><tr><td>  Normalized AUC RSSI</td><td>− 0.014</td><td>0.92</td></tr><tr><td colspan="3">Clinical outcome at 1 year</td></tr><tr><td>Modified Rankin scale</td><td>0.149</td><td>0.26</td></tr><tr><td>ACE-R [???] #</td><td>− 0.067</td><td>0.67</td></tr></tbody></table></div>*BBB analyses were available in 59 patients (DCE data not available for 1 patient)# Available in 42 patientsNIHSS, National Institutes of Health Stroke Scale; AUC, area under the curve; RSSI, recent small subcortical infarct; DTI, diffusion tensor imaging; WMH, white matter hyperintensities; MD, mean diffusivity; FA, fractional anisotropy; ACE-R, Addenbrooke’s Cognitive Examination Revised</transformed-table></extracted-table></extracted-tables-set>